Experts believe that in Russia there is a need to revise the system for providing patients with medicines at the outpatient stage of treatment. According to the Federal State Budgetary Scientific Institution National Research Institute of Public Health named after N. A. Semashko, ”about 10-12% of the population are covered by state drug support programs with such treatment.
Source: Фармацевтический вестник